News and Announcements
Altech has Robust Outlook for Global HPA as Demand is Confirmed
- Published November 23, 2016 11:11AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd November 2016, ASX Announcement
Highlights
- Global HPA demand increased by 19.5% in 2015
- Annual HPA demand forecast of 86,831tpa by 2024 (est. 2016: 25,315tpa)
- Altech’s strategy of focusing on 4N HPA endorsed
- HPA use in lithium-ion batteries offers incremental demand
- Current reported HPA price in Japan is ~US$30,000/t
- Threat of substitutes for HPA remains low
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide an update on the outlook for global high purity alumina (HPA) demand from a report entitled “High Purity Alumina Market – Global Industry Analysis and Forecast, 2016 – 2024” by Persistence Market Research (“Persistence”), commissioned as part of the current project debt funding due diligence program.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
